The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Sizing for self-expanding transcatheter aortic valve implantation
EuroIntervention 2018;14:e490-e493 published online e-edition August 2018. DOI: 10.4244/EIJV14I5A86
Hasan Jilaihawi, MD; Zhen-Gang Zhao, MD; Mathew Williams, MD
NYU Langone Health, New York, NY, USA
Computed tomography (CT) is the standard of care for device sizing for balloon-expandable (BE) and self-expanding (SE) transcatheter aortic valve implantation (TAVI) and has dramatically impacted outcomes in this field, particularly the frequency of paravalvular aortic regurgitation (PAR)1,2. In this issue of EuroIntervention, Kim et al describe multicentric outcomes of 198 patients treated with a novel SE transcatheter heart valve (THV) device, the Edwards CENTERA (Edwards Lifesciences, Irvine, CA, USA) in the context of CT-based oversizing, as assessed prospectively by a dedicated CT core lab3.
The Edwards CENTERA is a relatively novel THV whose first-in-man (FIM) experience was described ...